GC Cell
144510.KQ
16.48 USD
-0.66
-3.85%
g
Overview
Last close
16.48 usd
Market cap
247.72M usd
52 week high
36.44 usd
52 week low
14.70 usd
Target price
51.26 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
1.9481
Price/Book Value
0.6983
Enterprise Value
322.66M usd
EV/Revenue
2.5268
EV/EBITDA
32.3865
Key financials
Revenue TTM
127.75M usd
Gross Profit TTM
67.15M usd
EBITDA TTM
7.01M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
504.91M usd
Net debt
N/A usd
About
GC Cell Corporation develops cell therapy products. It also provides cell banking, sample inspection, clinical trial, and bio logistics services. Its main product is Immuncell-LC. GC Cell Corporation has strategic agreement with Lukas Biomedical Co., Ltd. to develop Cell therapy. The company was formerly known as Green Cross Lab Cell Corporation and changed its name to GC Cell Corporation in November 2021. GC Cell Corporation was founded in 2011 and is based in Yongin-si, South Korea.
- Symbol144510.KQ
- ExchangeKQ
- IsinKR7144510005
- CountrySouth Korea
- SectorHealthcare
- IndustryDiagnostics & Research
- CEOJong-Eun Park
- HeadquarterYongin-si
- Web sitehttps://www.gccell.com
